tetano
Editor, Senior Moderator
Am J Epidemiol
. 2020 Jul 22;kwaa158.
doi: 10.1093/aje/kwaa158. Online ahead of print.
HIV and SARS-CoV-2: Intersecting Epidemics with Many Unknowns
Catherine R Lesko[SUP] 1 [/SUP], Angela M Bengtson[SUP] 2 [/SUP]
Affiliations
Abstract
As of July 2020, approximately 6 months into the pandemic of novel coronavirus disease 2019 (COVID-19), whether people living with HIV (PLWH) are disproportionately affected remains an unanswered question. Thus far, risk of COVID-19 in people with and without HIV appears similar but data are sometimes contradictory. Some uncertainty is due to the recency of the emergence of COVID-19 and sparsity of data; some is due to imprecision about what it means for HIV to be a "risk factor" for COVID-19. Forthcoming studies on the risk of COVID-19 to PLWH should differentiate between 1) the unadjusted, excess burden of disease among PLWH to inform surveillance efforts; and 2) any excess risk of COVID-19 among PLWH due to biological effects of HIV, independent of comorbidities that confound rather than mediate this effect. PLWH bear a disproportionate burden of alcohol, other drug use, mental health disorders, and other structural vulnerabilities, which may increase their risk of COVID-19. In addition to any direct effects of COVID-19 on the health of PLWH, we need to understand how physical distancing restrictions impact secondary health outcomes, and the need for, accessibility of, and impact of alternative modalities of providing ongoing medical, mental health, and substance use treatment that comply with physical distancing restrictions (e.g., telemedicine).
Keywords: COVID-19; Engagement in care; HIV; Mental health; Substance use; Telemedicine.
. 2020 Jul 22;kwaa158.
doi: 10.1093/aje/kwaa158. Online ahead of print.
HIV and SARS-CoV-2: Intersecting Epidemics with Many Unknowns
Catherine R Lesko[SUP] 1 [/SUP], Angela M Bengtson[SUP] 2 [/SUP]
Affiliations
- PMID: 32696057
- DOI: 10.1093/aje/kwaa158
Abstract
As of July 2020, approximately 6 months into the pandemic of novel coronavirus disease 2019 (COVID-19), whether people living with HIV (PLWH) are disproportionately affected remains an unanswered question. Thus far, risk of COVID-19 in people with and without HIV appears similar but data are sometimes contradictory. Some uncertainty is due to the recency of the emergence of COVID-19 and sparsity of data; some is due to imprecision about what it means for HIV to be a "risk factor" for COVID-19. Forthcoming studies on the risk of COVID-19 to PLWH should differentiate between 1) the unadjusted, excess burden of disease among PLWH to inform surveillance efforts; and 2) any excess risk of COVID-19 among PLWH due to biological effects of HIV, independent of comorbidities that confound rather than mediate this effect. PLWH bear a disproportionate burden of alcohol, other drug use, mental health disorders, and other structural vulnerabilities, which may increase their risk of COVID-19. In addition to any direct effects of COVID-19 on the health of PLWH, we need to understand how physical distancing restrictions impact secondary health outcomes, and the need for, accessibility of, and impact of alternative modalities of providing ongoing medical, mental health, and substance use treatment that comply with physical distancing restrictions (e.g., telemedicine).
Keywords: COVID-19; Engagement in care; HIV; Mental health; Substance use; Telemedicine.